These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2842266)

  • 1. Prevention of postoperative deep vein thrombosis by two different heparin types.
    Catania G; Salanitri G
    Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):304-9. PubMed ID: 2842266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low molecular weight heparin prevention of post-operative deep vein thrombosis in vascular surgery.
    Speziale F; Verardi S; Taurino M; Nicolini G; Rizzo L; Fiorani P; Palazzini E
    Pharmatherapeutica; 1988; 5(4):261-8. PubMed ID: 3174726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of low molecular weight heparin in the prevention of postoperative deep venous thrombosis. Our experience in 88 cases].
    Verardi S; Cortese F; Baroni B; Boffo V; Casciani CU
    G Chir; 1989 Nov; 10(11):674-8. PubMed ID: 2562010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of deep venous thrombosis by a new low molecular weight heparin (Fluxum) in cardiac surgery.
    Beghi C; Fragnito C; Antonelli A; Reverberi C; Ferrari P; Saccani S; Fesani F
    Int Angiol; 1993 Dec; 12(4):383-6. PubMed ID: 8207317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicentre study on LMW-heparin effectiveness in preventing postsurgical thrombosis.
    Verardi S; Casciani CU; Nicora E; Forzano F; Origone A; Valle I; Catania G; Salanitri G; Salcuni P; Azzarone M
    Int Angiol; 1988; 7(3 Suppl):19-24. PubMed ID: 2850322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Leyvraz PF; Richard J; Bachmann F; Van Melle G; Treyvaud JM; Livio JJ; Candardjis G
    N Engl J Med; 1983 Oct; 309(16):954-8. PubMed ID: 6621623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of postoperative deep vein thrombosis in cancer patients. A randomized trial with low molecular weight heparin (CY 216).
    Marassi A; Balzano G; Mari G; D'Angelo SV; Della Valle P; Di Carlo V; D'Angelo A
    Int Surg; 1993; 78(2):166-70. PubMed ID: 8394842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low molecular weight heparin (Logiparin) as thromboprophylaxis in elective abdominal surgery. A dose finding study.
    Hauch O; Jørgensen LN; Kølle TR; Nerstrøm H; Schebye O; Wille-Jørgensen P; Ostergaard P
    Acta Chir Scand Suppl; 1988; 543():90-5. PubMed ID: 2847464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.
    Simonneau G; Charbonnier B; Decousus H; Planchon B; Ninet J; Sie P; Silsiguen M; Combe S
    Arch Intern Med; 1993 Jul; 153(13):1541-6. PubMed ID: 8391792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the effectiveness and safety of Fragmin (Kabi 2165) versus calcium heparin in the prevention of deep venous thrombosis in general surgery].
    Creperio G; Marabini M; Ciocia G; Bergonzi M; Fincato M
    Minerva Chir; 1990 Sep; 45(17):1101-6. PubMed ID: 2177861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of a very low molecular weight heparin fragment (CY 222) compared to standard heparin in patients with deep venous thrombosis. A randomized study].
    Faivre R; Neuhart E; Kieffer Y; Bassand JP; Maurat JP
    J Mal Vasc; 1987; 12 Suppl B():145-6. PubMed ID: 2834488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.
    Hull RD; Raskob GE; Pineo GF; Feldstein W; Rosenbloom D; Gafni A; Green D; Feinglass J; Trowbridge AA; Elliott CG
    Arch Intern Med; 1997 Feb; 157(3):298-303. PubMed ID: 9040296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Low-molecular-weight heparin for preventing deep-vein thrombosis after total joint arthroplasty].
    Yang G; Lu H; Gao J; Kou B; Yuan Y; Xu B
    Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):25-7. PubMed ID: 11831980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of complications of major orthopedic surgery: comparison of indobufen, calcium heparin, and low molecular heparin].
    Borghi B; Bassi A; Grazia M; Feoli MA; Pignotti E
    Minerva Anestesiol; 1996 Mar; 62(3):93-100. PubMed ID: 8767154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population.
    Ugaki H; Enomoto T; Fujiwara K; Kimura T; Kawasaki T
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):585-9. PubMed ID: 18685443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low doses of heparin and heparin dihydergot in postoperative thromboprophylaxis in gynaecological patients.
    Urlep-Salinović V; Jelatancev B; Gorisek B
    Thromb Haemost; 1994 Jul; 72(1):16-20. PubMed ID: 7974365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enoxaparin in the prevention of deep venous thrombosis after major surgery: multicentric study. The Italian Study Group.
    Gazzaniga GM; Angelini G; Pastorino G; Santoro E; Lucchini M; Dal Prà ML
    Int Surg; 1993; 78(3):271-5. PubMed ID: 8276557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of intimal hyperplasia with low molecular weight heparin in a sheep model.
    Ao PY; Hawthorne WJ; Coombs R; Fletcher JP
    Int Angiol; 1999 Jun; 18(2):131-9. PubMed ID: 10424369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.